Skip to content

Stefania Chiappini

29 papers in the library · 744 citations · publishing 2015-2026

Papers

Sort Most recent Most cited

How does ayahuasca work from a psychiatric perspective? Pros and cons of the entheogenic therapy.

Human Psychopharmacology: Clinical and Experimental May 1, 2020 Laura Orsolini, Stefania Chiappini, Duccio Papanti et al. 27 citations

Ayahuasca is a hallucinogenic plant preparation, traditionally consumed in sacred ceremonies by indigenous North-Westerner Amazonian countries like Colombia, Peru, Brazil, and Ecuador. It is fundamental to carefully balance benefits/risks related to the ayahuasca intake, both during ceremonies and experimental settings. The aim is at evaluating and comparing the potential therapeutic benefits...

The Bridge Between Classical and “Synthetic”/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective

Frontiers in Psychiatry November 20, 2019 Laura Orsolini, Stefania Chiappini, Duccio Papanti et al. 41 citations

The critical spread and dissemination of novel psychoactive substances (NPS), particularly among the most vulnerable youngsters, may pose a further concern about the psychotic trajectories related to the intake of new synthetic drugs. The psychopathological pattern of the "new psychoses" appears to be extremely different from the classical presentation. Therefore, clinicians need more data on...

DOI: 10.3389/fpsyt.2019.00851 (opens in new tab) Addiction Psychopathology Synthetic cannabinoids Perspective graphical +3

New/emerging psychoactive substances and associated psychopathological consequences

Psychological Medicine July 22, 2019 Fabrizio Schifano, Flavia Napoletano, Stefania Chiappini et al. 118 citations

BACKGROUND: The present paper provides an updated review of both the large number of new/novel/emerging psychoactive substances (NPS) and their associated psychopathological consequences. Focus was here given on identification of those NPS being commented in specialised online sources and the related short-/long-term psychopathological and medical ill-health effects. METHODS: NPS have been...

DOI: 10.1017/s0033291719001727 (opens in new tab) Psychopathology Medical prescription Synthetic cannabinoids Mental health +2

Methoxetamine‐related deaths in the UK: an overview

Human Psychopharmacology: Clinical and Experimental July 1, 2015 Stefania Chiappini, Hugh Claridge, John Corkery et al. 45 citations

OBJECTIVE: The goal of this study is to provide an update on the data given on methoxetamine (MXE)-related fatalities that occurred in 2011-2013, presented at the Second International Conference on Novel Psychoactive Substances. METHODS: Fatalities involving MXE were extracted from the database of the National Programme on Substance Abuse Deaths, which receives information on drug-related...